Two major risk factors for bladder cancer are smoking and occupational exposure to chemicals. The XPC protein is crucial in the recognition and initiation of the nucleotide excision repair pathway which repairs the DNA adducts formed by carcinogens found in cigarette smoke and chemicals. Polymorphisms in the XPC gene have been shown to influence an individual's DNA repair capacity, and hence, increase that individual's susceptibility to cancer. We undertook a case-control study of 547 bladder cancer cases and 579 cancer-free controls to investigate the association between 22 XPC polymorphisms and bladder cancer susceptibility, and investigated gene-environment interactions. We showed that the nonsynonymous polymorphism Ala 499 Val was in strong linkage disequilibrium with two polymorphisms in the 3 ¶-untranslated region (Ex15-184 and Ex15-177) with Lewontin's D ¶ z 0.99 and r 2 z 0.82. Individuals homozygous for the minor allele of Ala 499 Val, Ex15-184, or Ex15-177 had an increased risk of bladder cancer compared with those homozygous for the common allele [adjusted odds ratio (95% confidence interval), 1.65 (1.05-2.59), 1.82 (1.12-2.97), and 1.82 (1.12-2.96), respectively]. The associations were somewhat stronger for smokers and those occupationally exposed to chemicals, although tests for gene-environment interactions were not significant. (Cancer Epidemiol Biomarkers Prev 2006; 15(12):2537 -41) 
Introduction
Carcinogens in tobacco smoke and industrial chemicals are two major risk factors for transitional cell carcinoma (TCC). The bulky DNA adducts formed by these carcinogens are repaired by nucleotide excision repair. Reduced DNA repair capacity (DRC) is associated with an increased cancer risk (1) . Inherited polymorphisms in DNA repair genes might influence an individual's DRC (2) by altering amino acid sequences, mRNA splicing, and transcription efficiency.
The xeroderma pigmentosum complementation group C (XPC) protein is involved in the recognition and initiation of the global genome repair pathway of nucleotide excision repair. XPC binds to HR23B to form the stable XPC-HR23B complex, which recognizes and binds to damaged DNA (3) . XPC protein deficiency causes the clinical disorder xeroderma pigmentosum, characterized by extreme sensitivity to sunlight and an increased risk of skin cancer (4) . Similarly, XPC knockout (XPCÀ/À) mice are susceptible to UV-induced skin tumors (5) , but may also develop acetylaminofluorene-induced lung and liver tumors (6) .
To date, only five XPC polymorphisms have been studied in bladder cancer, i.e., Arg 492 His, Ala 499 Val, Lys 939 Gln, intervening sequence (IVS) 11-6, and poly(AT) (intron 9; refs. [7] [8] [9] [10] . Although three studies, including the larger studies of Wu et al. and Garcia-Closas et al. showed no association with bladder cancer risk (8-10), Sanyal et al. (7) found an increased risk for cases with the Lys 939 Gln homozygous variant. Also, variants of Lys 939 Gln, IVS11-6, and poly(AT) have been associated with increased risk of various other cancers (11) (12) (13) . The IVS11-6 (A to C transition) at intron 11 causes abnormal mRNA splicing with skipping of exon 12 and hence reduced DRC (14) . The poly(AT) (insertion/ deletion) polymorphism in intron 9 was associated with reduced DRC in a normal population (15) . The Lys 939 Gln (A to C transition) was found to influence irradiation-specific DNA repair in normal human lymphocytes (16) . We hypothesized that other XPC polymorphisms may also influence DRC and hence bladder cancer risk. Therefore, we undertook a large study in TCC bladder cases and controls of 22 potentially functional XPC polymorphisms.
Materials and Methods
Study Subjects. The design of this case-control study has been described in detail previously (8) . Briefly, 547 cases of bladder TCC were recruited from August 2002 to April 2004 at our institution in Leeds, United Kingdom. Five hundred and seventy-nine cancer-free controls were recruited from the community from 1997 to 2000 (n = 227; ref. 17) and from the hospital otolaryngology and ophthalmology departments from 2002 to 2004 (n = 352) in the same region. Each subject donated a blood sample and completed a structured health questionnaire regarding smoking, occupation, and family history. Occupational exposure was defined as participating in occupations involving rubber/plastics industries, laboratories, printing, paints, dyes, or diesel fumes. Histopathologic information regarding tumor stage and grade were obtained from hospital records.
Genotyping. We selected XPC polymorphisms based on potential function rather than on patterns of linkage disequilibrium. Hence, all the XPC polymorphisms with allele frequencies of >1.0% located in the promoter region (up to 1,000 bases upstream of the gene), 5 ¶ and 3 ¶ untranslated region (UTR), and exons were selected. Only those polymorphisms in the intronic regions with known or potential splicing effects (within 100 bases up and downstream of an exon) were selected (15% of all intronic single nucleotide polymorphisms of >1% allele frequency). The 22 polymorphisms chosen for this study are listed in Table 1 . Details of the genotyping using TaqMan techniques have been described previously (8) . The primer and probe sets used are listed in Supplementary Table S1 . As a quality control measure, 5% of the samples (n = 57) were re-genotyped with 100% concordance.
Statistical Analysis. All data were analyzed as previously described (8) using the Stata software version 8 (College Station, Statacorp, TX). We had 90%, 78%, and 55% power to detect an odds ratio (OR) of 1.50 for carriage of the minor allele with frequencies at 0.20, 0.10, and 0.05, respectively (twosided, P = 0.05). Gene-environment interactions were assessed by stratification of subjects based on smoking status and occupational exposure, and P values were calculated based on the likelihood-ratio test. Haplotypes for the gene were estimated based on the expectation maximization algorithm using the program SIMHAP (http://www.genepi.com.au/ projects/simhap/). A P = 0.05 for any test or model was considered to be statistically significant.
Results
Study Subjects. The demographic characteristics of the cases and controls have been described previously (8) . The participation rate for cases and controls were 99% and 80%, respectively. The majority of subjects were Caucasian (98.6%) with no difference in mean age (cases, 72.8 years; controls, 71.9 years), although cases were more likely to be male (70.9% versus 65.5%, P = 0.05). Smoking prevalence was higher in cases (78% versus 66%, P < 0.001) as was occupational exposure (27.4% versus 16.8%, P < 0.001), and family history of bladder cancer (4.8% versus 2.2%, P = 0.02).
Genotyping. Genotyping was successful in 96.2% of samples (range, 91.7-99.6% for individual polymorphisms). The control genotype distributions were all in HardyWeinberg equilibrium. Although there were no significant differences among coding polymorphisms in genotype distributions between the two control groups, differences were found in two intronic polymorphisms (IVS11-37 and IVS14-51) at the 5% level (minor allele frequency, 0.54 versus 0.45; P = 0.01 and 0.29 versus P = 0.25 and 0.04, respectively). However, this was consistent with random variation, given the number of polymorphisms examined, so the two control groups were combined to increase our power to detect an association between the polymorphisms and bladder cancer risk.
The 22 XPC polymorphisms exhibited strong linkage disequilibrium (Supplementary Table S2 ). We have previously shown the strong linkage disequilibrium between XPC poly(AT), IVS11-6, and Lys 939 Gln (8) . In addition, we also found strong linkage disequilibrium between Ala 499 Val and two polymorphisms in the 3 ¶UTR (Ex15-184 and Ex15-177; D ¶ z 0.99 and r 2 z 0.82). From Supplementary Gene-Environment Interactions. To examine gene-environment interactions, individuals were stratified by smoking status (nonsmokers and combined ex-and current smokers) and occupational exposure (exposure and no exposure), and the association analyses were repeated ( 
